163 related articles for article (PubMed ID: 20219875)
1. Enzyme-linked immunosorbent assay for measurement of cytomegalovirus glycoprotein B antibody in serum.
Hackett DJ; Zhang C; Stefanescu C; Pass RF
Clin Vaccine Immunol; 2010 May; 17(5):836-9. PubMed ID: 20219875
[TBL] [Abstract][Full Text] [Related]
2. Detection of cytomegalovirus infection during clinical trials of glycoprotein B vaccine.
Zhang C; Pass RF
Vaccine; 2004 Dec; 23(4):507-10. PubMed ID: 15530699
[TBL] [Abstract][Full Text] [Related]
3. Optimized enzyme-linked immunosorbent assay for detecting cytomegalovirus infections during clinical trials of recombinant vaccines.
Pagnon A; Piras F; Gimenez-Fourage S; Dubayle J; Arnaud-Barbe N; Hessler C; Caillet C
J Clin Virol; 2017 Nov; 96():99-104. PubMed ID: 29035763
[TBL] [Abstract][Full Text] [Related]
4. Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: seroconversion and viral shedding.
Zhang C; Buchanan H; Andrews W; Evans A; Pass RF
J Clin Virol; 2006 Mar; 35(3):338-42. PubMed ID: 16388984
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients.
Marshall GS; Li M; Stout GG; Louthan MV; Duliège AM; Burke RL; Hunt LA
Viral Immunol; 2000; 13(3):329-41. PubMed ID: 11016597
[TBL] [Abstract][Full Text] [Related]
6. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies.
Busse C; Strubel A; Schnitzler P
J Clin Virol; 2008 Oct; 43(2):137-41. PubMed ID: 18621576
[TBL] [Abstract][Full Text] [Related]
7. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens.
Weber B; Fall EM; Berger A; Doerr HW
J Clin Virol; 1999 Dec; 14(3):173-81. PubMed ID: 10614854
[TBL] [Abstract][Full Text] [Related]
8. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin.
Drulak MW; Malinoski FJ; Fuller SA; Stewart SS; Hoskin S; Duliege AM; Sekulovich R; Burke R; Winston S
Viral Immunol; 2000; 13(1):49-56. PubMed ID: 10733168
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.
Marshall GS; Rabalais GP; Stout GG; Waldeyer SL
J Infect Dis; 1992 Feb; 165(2):381-4. PubMed ID: 1309850
[TBL] [Abstract][Full Text] [Related]
11. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).
Adler SP; Plotkin SA; Gonczol E; Cadoz M; Meric C; Wang JB; Dellamonica P; Best AM; Zahradnik J; Pincus S; Berencsi K; Cox WI; Gyulai Z
J Infect Dis; 1999 Sep; 180(3):843-6. PubMed ID: 10438376
[TBL] [Abstract][Full Text] [Related]
12. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
Rahbar AR; Sundqvist VA; Wirgart BZ; Grillner L; Söderberg-Naucler C
Transfusion; 2004 Jul; 44(7):1059-66. PubMed ID: 15225248
[TBL] [Abstract][Full Text] [Related]
13. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
14. [CMV antibody determination with two enzyme immunoassays in each case].
Albert S; Sibrowski W; Kühnl P; Knödler B; Seidl S; Böhm BO; Doerr HW
Beitr Infusionsther; 1990; 26():40-2. PubMed ID: 1703884
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.
Bernstein DI; Munoz FM; Callahan ST; Rupp R; Wootton SH; Edwards KM; Turley CB; Stanberry LR; Patel SM; Mcneal MM; Pichon S; Amegashie C; Bellamy AR
Vaccine; 2016 Jan; 34(3):313-9. PubMed ID: 26657184
[TBL] [Abstract][Full Text] [Related]
16. Avidity maturation following immunization with two human cytomegalovirus (CMV) vaccines: a live attenuated vaccine (Towne) and a recombinant glycoprotein vaccine (gB/MF59).
Marshall BC; Adler SP
Viral Immunol; 2003; 16(4):491-500. PubMed ID: 14733736
[TBL] [Abstract][Full Text] [Related]
17. A Novel Multiplexed Enzyme-Linked Immunosorbent Assay for the Detection of IgG Seroreactivity to Cytomegalovirus (CMV) UL144.
Miller H; Simpson P; Forman M; Prigan A; Kehl S; Mesich B; Faron M; Ledeboer N; Arav-Boger R
J Clin Microbiol; 2021 Jul; 59(8):e0096421. PubMed ID: 34076473
[TBL] [Abstract][Full Text] [Related]
18. Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.
Bernstein DI; Schleiss MR; Berencsi K; Gonczol E; Dickey M; Khoury P; Cadoz M; Meric C; Zahradnik J; Duliege AM; Plotkin S
J Infect Dis; 2002 Mar; 185(5):686-90. PubMed ID: 11865427
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
[TBL] [Abstract][Full Text] [Related]
20. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.
Schleiss MR; Bourne N; Stroup G; Bravo FJ; Jensen NJ; Bernstein DI
J Infect Dis; 2004 Apr; 189(8):1374-81. PubMed ID: 15073673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
